Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1785Other hematologic neoplasm 714Plasma cell 290Dermatologic 287Myeloid 244Sarcoma 187Genitourinary 92CNS 86Breast 81Gynecologic 75Classical hematology 59Thoracic 46Gastrointestinal 38Other neoplasm 37Head & Neck 25Other solid neoplasm 9Endocrine 4Other 1

Conditions

Obesity 410Neoplasms 151Mucositis 128Sexual Dysfunction, Physiological 105Breast Neoplasms 105Polycystic Ovary Syndrome 98Overweight 98Dyspnea 62Constipation 57Motor Activity 54Head and Neck Neoplasms 47Prostatic Neoplasms 42Weight Loss 39Diabetes Mellitus 36Pain 34Colorectal Neoplasms 33Endometrial Neoplasms 29Stomatitis 28Opioid-Induced Constipation 28Lung Neoplasms 28Depression 26Diabetes Mellitus, Type 2 24Cardiovascular Diseases 23Obesity, Morbid 22Multiple Endocrine Neoplasia Type 1 22Insulin Resistance 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Anxiety Disorders 21Hypertension 19Sexual Dysfunctions, Psychological 18

Interventions

glucarpidase 1Radiotherapy 1Methotrexate 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large B-Cell, Diffuse × Other × Clear all
NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡